Victoria Rutherford
Investor Relations
Replay available
Medexus Pharmaceuticals Inc. (TSX: MDP) Q2 2026 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Research Capital
Analyst, Raymond James
Analyst, AGP
Analyst, Bloom Burton
Watch the replay and follow the connected company analysis, news, and investor updates for Medexus Pharmaceuticals Inc..
WEBVTT 00:00:00.031 -- 00:00:05.476 Good morning, everyone, and welcome to the MedExus Pharmaceuticals First Quarter 00:00:05.476 -- 00:00:10.601 2026 Conference Call. At this time, all participants are in 00:00:10.601 -- 00:00:16.446 a listen-only mode, and the floor will be open for questions following the presentation. 00:00:16.446 -- 00:00:20.830 If anyone should require operator assistance during this conference, please press star 00:00:20.830 -- 00:00:25.775 zero on your phone keypad. Please note this conference is being recorded. 00:00:25.775 -- 00:00:31.113 I will now turn the conference over to your host, Victoria Rutherford, Investor Relations. 00:00:31.113 -- 00:00:34.494 Victoria, the floor is yours. 00:00:34.637 -- 00:00:39.622 Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals 00:00:39.622 -- 00:00:44.947 first fiscal quarter 2026 earnings call. On the call this morning are Ken John-Tremont, 00:00:44.947 -- 00:00:49.232 Chief Executive Officer, and Brendan Bushman, Chief Financial Officer. 00:00:49.232 -- 00:00:52.996 If you have any questions after the conference call or would like further information 00:00:52.996 -- 00:00:59.527 about the company, please contact Adelaide Capital at 480- I would 00:01:00.651 -- 00:01:04.515 like to remind everyone that this discussion will include forward-looking information 00:01:04.515 -- 00:01:09.241 as defined in Canadian securities laws that is based on certain assumptions that Medexis 00:01:09.241 -- 00:01:15.048 believes to be reasonable in the circumstances that is subject to risks and uncertainties. 00:01:15.048 -- 00:01:20.013 Actual results may differ materially from historical results or results anticipated by 00:01:20.013 -- 00:01:25.279 the forward-looking information. In additi...